Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL38 pseudogene 4 (RPL38P4) is a processed pseudogene derived from the ribosomal protein L38 (RPL38) gene, present in the human genome. Unlike its functional parent gene, RPL38, this pseudogene does not encode a protein and lacks regulatory elements necessary for function. It is not involved in protein synthesis, development, or disease association. Multiple processed pseudogenes for ribosomal protein genes occur throughout the genome, and while some may have regulatory roles or affect the expression of neighboring genes (such as a pseudogene in the angiotensin II receptor promoter), no evidence implicates RPL38P4 as a functional molecule or therapeutic target[1][4][7]. Explanation: - The canonical RPL38 gene encodes the 60S ribosomal protein L38, which is a component of the large ribosomal subunit with key functions in translation and embryonic patterning[1][2][5][6][7]. However, RPL38P4 is a pseudogene: it is a duplicated, non-functional DNA sequence that does not encode a protein; such sequences are not considered molecular targets or relevant to drug development[1][4][7]. - There is no evidence in the provided material or public genetic databases that RPL38P4 is a therapeutic target, receptor, enzyme, or involved in any disease process. - All referenced disease associations, molecular functions, or biological activities relate to functional RPL38, not its pseudogenes[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL38 pseudogene 4 (RPL38P4).